Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment

Background and Objectives: Brolucizumab (IVBr) is a recently introduced anti-vascular endothelial growth factor (anti-VEGF) which has been found to be very effective in treating neovascular age-related macular degeneration (nAMD). We reported our findings in a case of nAMD that developed intraocular...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueji, Natsuki, Mase, Yoko, Kubo, Akiko, Matsubara, Hisashi, Chujo, Shinichiro, Matsui, Yoshitsugu, Kondo, Mineo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608434/
https://www.ncbi.nlm.nih.gov/pubmed/37893574
http://dx.doi.org/10.3390/medicina59101856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608434/
https://www.ncbi.nlm.nih.gov/pubmed/37893574
http://dx.doi.org/10.3390/medicina59101856

Ejemplares similares